# Medicaments (HS4 3004) Trade Overview | Yugalinks

> Published by **Yugalinks**, global trade intelligence for growing businesses.
>
> [Follow Yugalinks on LinkedIn](https://in.linkedin.com/company/yugalinks)

Medicaments at HS4 3004, with reported global trade through 2024.

Canonical: https://www.yugalinks.com/trade/sector/hs4/3004

## Explore Yugalinks

- [Open the trade workspace](https://www.yugalinks.com/app)
- [Read the methodology](https://www.yugalinks.com/methodology)
- [Review data sources](https://www.yugalinks.com/data-sources)
- [Check data coverage](https://www.yugalinks.com/data-coverage)
- [Read Responsible AI principles](https://www.yugalinks.com/responsible-ai)

## Answer

The medicaments subsector recorded $487.4B in reported global trade in 2024, with -0.6% annual change.

## Key figures

| Measure | Value |
| --- | --- |
| Latest reported trade | $487.4B |
| Latest annual change | -0.6% |
| Active exporters | 195 |
| Active importers | 200 |
| Active HS6 products | 12 |

## Annual trend

| Year | Global trade | Corridors | HS6 products |
| --- | ---: | ---: | ---: |
| 1995 | $38.3B | 6,567 | 12 |
| 1996 | $41.8B | 6,608 | 12 |
| 1997 | $47.2B | 6,614 | 12 |
| 1998 | $55.1B | 6,894 | 12 |
| 1999 | $69.9B | 7,296 | 12 |
| 2000 | $73.5B | 8,062 | 12 |
| 2001 | $92.8B | 8,226 | 12 |
| 2002 | $121.1B | 8,500 | 12 |
| 2003 | $148.9B | 8,658 | 12 |
| 2004 | $178.7B | 8,919 | 12 |
| 2005 | $197.6B | 9,129 | 12 |
| 2006 | $227.3B | 9,338 | 12 |
| 2007 | $265.2B | 9,504 | 12 |
| 2008 | $299.6B | 9,573 | 12 |
| 2009 | $311.3B | 9,939 | 12 |
| 2010 | $301.8B | 10,026 | 12 |
| 2011 | $321.8B | 10,365 | 12 |
| 2012 | $314.6B | 10,650 | 12 |
| 2013 | $320.6B | 10,556 | 12 |
| 2014 | $337.0B | 10,901 | 12 |
| 2015 | $320.1B | 10,917 | 12 |
| 2016 | $328.0B | 11,044 | 12 |
| 2017 | $333.2B | 11,101 | 12 |
| 2018 | $361.3B | 11,249 | 12 |
| 2019 | $379.9B | 11,264 | 12 |
| 2020 | $407.7B | 11,785 | 12 |
| 2021 | $426.5B | 11,844 | 12 |
| 2022 | $457.7B | 11,799 | 12 |
| 2023 | $463.4B | 11,687 | 12 |
| 2024 | $487.4B | 11,731 | 12 |

## Leading corridors

- Slovenia to Switzerland, Liechtenstein: $19.7B; growth +83%.
- Switzerland, Liechtenstein to USA, Puerto Rico and US Virgin Islands: $13.6B; growth -5.7%.
- Ireland to USA, Puerto Rico and US Virgin Islands: $11.1B; growth +0.9%.
- India to USA, Puerto Rico and US Virgin Islands: $10.3B; growth +10.8%.
- Germany to USA, Puerto Rico and US Virgin Islands: $9.3B; growth -4.8%.
- Italy to Switzerland, Liechtenstein: $8.5B; growth +41%.
- Italy to USA, Puerto Rico and US Virgin Islands: $7.8B; growth +28.4%.
- Canada to USA, Puerto Rico and US Virgin Islands: $7.4B; growth +8.4%.
- Italy to Belgium: $6.8B; growth +4.9%.
- Switzerland, Liechtenstein to Slovenia: $6.2B; growth +15.5%.

## HS6 products

- Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale (HS6 300410)
- Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale (HS6 300420)
- Medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale (HS6 300431)
- Medicaments: containing corticosteroid hormones, their derivatives or structural analogues (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale (HS6 300432)
- Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale (HS6 300439)
- Medicaments: containing alkaloids or their derivatives (but not hormones or antibiotics), for therapeutic or prophylactic uses, packaged for retail sale (HS6 300440)
- Medicaments: containing alkaloids or their derivatives, containing ephedrine or its salts, for therapeutic or prophylactic uses, packaged for retail sale (HS6 300441)
- Medicaments: containing alkaloids or their derivatives, containing pseudoephedrine (INN) or its salts, for therapeutic or prophylactic uses, packaged for retail sale (HS6 300442)
- Medicaments: containing alkaloids or their derivatives, containing norephedrine or its salts, for therapeutic or prophylactic uses, packaged for retail sale (HS6 300443)
- Medicaments: containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts: for therapeutic or prophylactic uses, packaged for retail sale (HS6 300449)
- Medicaments: containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale (HS6 300450)
- Medicaments: containing antimalarial active principles described in Subheading Note 2 to this Chapter, for therapeutic or prophylactic uses, packaged for retail sale (HS6 300460)
- Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale (HS6 300490)

## Definitions and coverage

Merchandise trade observations aggregated to HS4. Growth, concentration, volatility, and peak comparisons calculated from reported observations. Missing values remain unavailable and are not imputed.

Reported observations cover 1995-2024.

## Continue your research

- [Explore HS4 3004 in the workspace](https://www.yugalinks.com/app?hs=3004)
- [Open the Yugalinks workspace](https://www.yugalinks.com/app)

## Other formats

- [HTML](https://www.yugalinks.com/trade/sector/hs4/3004/index.html)
- [JSON](https://www.yugalinks.com/trade/sector/hs4/3004/index.json)
- [JSON-LD](https://www.yugalinks.com/trade/sector/hs4/3004/index.ld.json)


## Continue your research

- [Explore HS4 3004 in the workspace](https://www.yugalinks.com/app?hs=3004)
- [Open the Yugalinks workspace](https://www.yugalinks.com/app)

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-27). [OECD Data Explorer](https://data-explorer.oecd.org/) · [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) · [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) · [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.